A Practical Guide to DLA-20 Assessment Workflows in Maryland PRP Programs

The Daily Living Activities (DLA-20) functional assessment is not optional in Maryland PRP programs. It is the foundation of medical necessity for Medicaid billing, the basis for Individual Rehabilitation Plan (IRP) goal-setting, and one of the first things a Carelon reviewer or OHCQ surveyor will ask to see. And yet, most PRP providers implement it inconsistently — assessments are late, scores are disconnected from care planning, and the longitudinal data that makes the DLA-20 genuinely useful for clinical decision-making sits unused in a filing cabinet.

This guide covers what COMAR actually requires, how to build a DLA-20 workflow that stays on schedule, and how to turn assessment data into meaningful clinical and operational intelligence.

What the DLA-20 Measures

The DLA-20 evaluates functional capacity across 20 domains of daily living, each scored on a 1–7 scale:

• 1–2: Total or severe dependence; unable to function in this domain without substantial support.
• 3–4: Moderate impairment; can function with regular support and prompting.
• 5–6: Mild impairment; mostly independent with occasional support.
• 7: Full independence; no impairment in this domain.

The 20 domains span health practices, housing stability, communication, safety, money management, transportation, grooming, personal hygiene, nutrition, impulse control, social network, leisure activities, community resources, work/school, problem-solving, substance use, family relationships, involvement in meaningful activities, ability to self-advocate, and medication management.

What makes the DLA-20 particularly relevant for PRP is that it directly measures the functional domains that rehabilitation services are designed to improve. Unlike a PHQ-9 or GAD-7 (which measure symptom severity), the DLA-20 measures ability to function in the community — which is the clinical justification for PRP services under Maryland Medicaid.

COMAR Requirements: What Is Actually Required

COMAR 10.21.09 requires a comprehensive assessment at intake that includes functional evaluation. The DLA-20 is the standard instrument used to satisfy this requirement. Beyond intake, reassessment is required at minimum every six months.

Here is the practical timeline most PRP programs should follow:

Intake (Day 0): Complete initial DLA-20 as part of the comprehensive assessment. This baseline establishes medical necessity and informs the initial IRP. Every domain should be scored, with clinical narrative supporting scores of 4 or below (these are the domains where PRP services are medically necessary).

IRP Development (Within 30 days of intake): Use the DLA-20 baseline to set IRP goals. There should be a clear line from low DLA-20 domain scores to specific rehabilitation goals. If a client scores a 2 on money management, the IRP should have a goal addressing money management skills. If a client scores a 3 on transportation, the IRP should address community mobility. This alignment between assessment and care plan is what surveyors look for.

6-Month Reassessment: Re-administer the full DLA-20. Compare scores to the baseline and to the most recent prior assessment. Document changes in functional status and update the IRP accordingly. If scores have improved, document what interventions drove the improvement and whether the client is approaching discharge readiness. If scores have declined or stagnated, document the clinical reasoning and any plan modifications.

Annual Comprehensive Reassessment: A full reassessment at the 12-month mark, which includes the DLA-20 plus a broader review of the client's clinical status, community integration, and rehabilitation progress. This informs IRP renewal and re-authorization.

Discharge: Final DLA-20 to document functional status at discharge. The comparison between intake and discharge scores is the single most powerful outcome measure for your PRP program.

Common Compliance Mistakes

Late Assessments

The most common OHCQ finding related to DLA-20 is simply that reassessments are overdue. A client enrolled for nine months with only an intake DLA-20 and no six-month reassessment is a compliance gap that surveyors will flag. The fix is systematic: your scheduling or tracking system needs to generate reminders at the five-month mark so clinicians have a 30-day window to complete the reassessment before the six-month deadline.

Scores Without Narrative

A DLA-20 with numbers but no supporting narrative is clinically incomplete and surveyors know it. A score of 2 on "Safety" could mean the client is actively suicidal, or it could mean they live in an unsafe neighborhood and lack awareness of personal safety strategies. The number alone does not tell the story. Each score at or below 4 should be accompanied by a brief clinical narrative explaining the basis for the score and its relevance to the rehabilitation plan.

Disconnected Scores and Care Plans

The DLA-20 exists to drive care planning. If a client's DLA-20 shows impairment in substance use (score of 2) and their IRP has no goal addressing substance use, there is a disconnection that reviewers will question. Every significantly impaired domain should either be addressed in the IRP or have a documented clinical reason why it is not being addressed (for example, the client is already receiving substance use treatment through a separate OTP and coordination is documented).

Static IRPs After Score Changes

When a six-month reassessment shows meaningful score changes — improvement or decline — the IRP should be updated. A client who improved from 2 to 5 on transportation no longer needs that goal on their IRP (or it should be updated to a maintenance goal). A client who declined from 4 to 2 on impulse control needs a new or modified goal. The IRP review should happen within 30 days of a reassessment that shows significant changes.

Building a Sustainable DLA-20 Workflow

Step 1: Centralize Your Assessment Schedule

Create a tracking system (even a simple spreadsheet, though an EHR-based tracker is better) that lists every enrolled PRP client with their intake date, last DLA-20 date, next DLA-20 due date, and assigned counselor. Run this report weekly and flag any clients whose reassessment is due within the next 30 days. This is the single most impactful workflow change you can make.

Step 2: Standardize Your Scoring Process

DLA-20 scoring should be consistent across clinicians. A score of 3 on "Communication" should mean the same thing whether Clinician A or Clinician B administered it. This requires calibration: have your clinical director or lead counselor facilitate a scoring calibration session at least annually, where clinicians independently score the same case vignette and discuss discrepancies. Without calibration, your longitudinal data is unreliable because score changes might reflect clinician interpretation differences rather than actual functional change.

Step 3: Integrate Scoring into the Assessment Template

The DLA-20 should not be a separate form that clinicians fill out and then transcribe into the chart. It should be embedded directly into the assessment workflow, with each domain's score entered alongside the supporting narrative. This reduces documentation time and ensures scores and narratives are always linked.

Step 4: Build Longitudinal Views

The real value of the DLA-20 emerges over time. A single assessment is a snapshot. Six months of assessments show a trajectory. Build a view (whether in your EHR, a spreadsheet, or a report) that shows each client's domain scores over time. This longitudinal view serves three purposes: clinical (identify which domains are responding to intervention and which are stagnant), authorization (demonstrate medical necessity for continued services by showing ongoing functional impairment), and outcomes (aggregate across your caseload to measure program effectiveness).

Step 5: Use Aggregate Data for Program Management

Once you have consistent, longitudinal DLA-20 data, you can answer questions that most PRP programs cannot: Which functional domains show the most improvement across our client population? Are certain clinicians achieving better outcomes in specific domains? What is the average length of time to meaningful functional improvement? At what DLA-20 score threshold are clients successfully maintaining in the community post-discharge?

This data is increasingly important as Maryland Medicaid moves toward value-based care. Providers who can demonstrate measurable functional improvement will be better positioned for enhanced reimbursement and preferred network status.